InvestorsHub Logo
Followers 230
Posts 15196
Boards Moderated 0
Alias Born 03/30/2005

Re: None

Monday, 10/05/2020 6:42:14 AM

Monday, October 05, 2020 6:42:14 AM

Post# of 403021
As information starts to go from pm to public, it's important not to set the bar too high

As a point of reference, my call with Leo a while back, as soon as I mentioned message board investment community, he quickly ended the call.

Some of you have picked up on my frustration with how the information is progressing and ipix's reticent stance. I have received supportive messages along with a few snarky comments.

There is more to the story that will come up in dribs and drabs to the public forum. My frustration is how the investment community is being handled here vs a select few. IPIX's PR's in August were very clear, yet anyone who questions the timeline is viewed as the enemy here or impatient.

The only thing that is clear, 60 days later the RBL is still nearing completion. The PRE-IND meeting request was granted to help the company file a subsequent IND " This pre-IND review will help result in a more efficient review of the subsequent IND
submission."
- that comes straight out of the May FDA report. The completeness of the Pre-IND determines how fast we get to the IND. Let's hope "nearing completion" won't be part of IPIX's Q&A

I hope restraint will be shown. Let the company do it's thing. I am happy Leo decided to leave Q4 human trials out of his last PR, however the sales pitch was still provided "Given such interest in Brilacidin, the Company anticipates the planned COVID-19 trial can be rapidly recruited and completed."

Now that we are in front of the FDA, let's see what IPIX updates come out.





the above is all IMHO (consider this my safe harbor statement)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News